These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

581 related articles for article (PubMed ID: 28496896)

  • 1. Left Atrial Appendage Occlusion for Stroke Prevention in Patients with Nonrheumatic Atrial Fibrillation.
    Sick PB
    J Atr Fibrillation; 2013; 6(3):923. PubMed ID: 28496896
    [No Abstract]   [Full Text] [Related]  

  • 2. Percutaneous closure of the left atrial appendage using the Amplatzer Cardiac Plug in patients with atrial fibrillation: evaluation of safety and feasibility.
    Streb W; Szymała M; Kukulski T; Nowak J; Lekston A; Sokal A; Knapik P; Czapla J; Zbieralska E; Kalarus Z
    Kardiol Pol; 2013; 71(1):8-16. PubMed ID: 23348528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial.
    Holmes DR; Kar S; Price MJ; Whisenant B; Sievert H; Doshi SK; Huber K; Reddy VY
    J Am Coll Cardiol; 2014 Jul; 64(1):1-12. PubMed ID: 24998121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation.
    Landmesser U; Holmes DR
    Eur Heart J; 2012 Mar; 33(6):698-704. PubMed ID: 22041550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
    Ramlawi B; Abu Saleh WK; Edgerton J
    Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience.
    Chun KR; Bordignon S; Urban V; Perrotta L; Dugo D; Fürnkranz A; Nowak B; Schmidt B
    Heart Rhythm; 2013 Dec; 10(12):1792-9. PubMed ID: 23973952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage.
    Boersma LV; Ince H; Kische S; Pokushalov E; Schmitz T; Schmidt B; Gori T; Meincke F; Protopopov AV; Betts T; Mazzone P; Foley D; Grygier M; Sievert H; De Potter T; Vireca E; Stein K; Bergmann MW;
    Circ Arrhythm Electrophysiol; 2019 Apr; 12(4):e006841. PubMed ID: 30939908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Percutaneous left atrial appendage occlusion in the prevention of stroke in atrial fibrillation: a systematic review.
    Baman JR; Mansour M; Heist EK; Huang DT; Biton Y
    Heart Fail Rev; 2018 Mar; 23(2):191-208. PubMed ID: 29453694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of Amulet Left Atrial Appendage Occluder and Watchman Device for Left Atrial Appendage Closure in Patients With Atrial Fibrillation.
    Sawaya F; Abi-Saleh B; Hoteit A; Jdaidany J; Moumneh MB; Harbieh B; Khoury M; Aramouni S; Abdulhai F; Refaat M
    Cureus; 2024 Mar; 16(3):e55531. PubMed ID: 38576630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation and contraindication for anticoagulation.
    Grosset-Janin D; Barth E; Bertrand B; Detante O
    Rev Neurol (Paris); 2015 May; 171(5):426-32. PubMed ID: 25912470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Assessment of Percutaneous Left-Atrial Appendage Occlusion (LAAO) Devices-A Single Center Cohort Study.
    Kayvanpour E; Kothe M; Kaya Z; Pleger S; Frey N; Meder B; Sedaghat-Hamedani F
    J Cardiovasc Dev Dis; 2024 May; 11(6):. PubMed ID: 38921657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left atrial appendage exclusion for stroke prevention in patients with nonrheumatic atrial fibrillation.
    Onalan O; Crystal E
    Stroke; 2007 Feb; 38(2 Suppl):624-30. PubMed ID: 17261703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplatzer Amulet Left Atrial Appendage Occluder Versus Watchman Device for Stroke Prophylaxis (Amulet IDE): A Randomized, Controlled Trial.
    Lakkireddy D; Thaler D; Ellis CR; Swarup V; Sondergaard L; Carroll J; Gold MR; Hermiller J; Diener HC; Schmidt B; MacDonald L; Mansour M; Maini B; O'Brien L; Windecker S
    Circulation; 2021 Nov; 144(19):1543-1552. PubMed ID: 34459659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left Atrial Appendage Occlusion/Exclusion: Procedural Image Guidance with Transesophageal Echocardiography.
    Vainrib AF; Harb SC; Jaber W; Benenstein RJ; Aizer A; Chinitz LA; Saric M
    J Am Soc Echocardiogr; 2018 Apr; 31(4):454-474. PubMed ID: 29158017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous closure of the left atrial appendage for prevention of thromboembolism in atrial fibrillation for patients with contraindication to or failure of oral anticoagulation: a single-center experience.
    Faustino A; Paiva L; Providência R; Trigo J; Botelho A; Costa M; Leitão-Marques A
    Rev Port Cardiol; 2013 Jun; 32(6):461-71. PubMed ID: 23639325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device.
    Miller MA; Gangireddy SR; Doshi SK; Aryana A; Koruth JS; Sennhauser S; d'Avila A; Dukkipati SR; Neuzil P; Reddy VY
    Heart Rhythm; 2014 Nov; 11(11):1853-9. PubMed ID: 25068574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial appendage exclusion-Where do we stand?
    Sakellaridis T; Argiriou M; Charitos C; Tsakiridis K; Zarogoulidis P; Katsikogiannis N; Kougioumtzi I; Machairiotis N; Tsiouda T; Arikas S; Mpakas A; Beleveslis T; Koletas A; Zarogoulidis K
    J Thorac Dis; 2014 Mar; 6 Suppl 1(Suppl 1):S70-7. PubMed ID: 24672702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left Atrial Appendage Ligation in Nonvalvular Atrial Fibrillation Patients at High Risk for Embolic Events With Ineligibility for Oral Anticoagulation: Initial Report of Clinical Outcomes.
    Sievert H; Rasekh A; Bartus K; Morelli RL; Fang Q; Kuropka J; Le D; Gafoor S; Heuer L; Safavi-Naeini P; Hue TF; Marcus GM; Badhwar N; Massumi A; Lee RJ
    JACC Clin Electrophysiol; 2015 Dec; 1(6):465-474. PubMed ID: 29759399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.